SCHEMBL29002480

SCHEMBL29002480

COc1nn(CF)cc1C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NNMT P40261 3/20 0.35
▸ GPR6 P46095 1/20 0.34
▸ POLB P06746 1/20 0.33
▸ MAPK8 P45983 3/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ ROCK1 Q13464 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ GLA P06280 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ MAP3K5 Q99683 3/20 0.32
▸ HTT P42858 2/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PARP1 P09874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29002512 0.88 KMT2A (0.36) NNMTGPR6POLBKMT2AROCK2
SCHEMBL22712271 0.85 POLB (0.40) GPR6POLBKMT2AKDM4EALDH1A1
SCHEMBL22712254 0.84 GAA (0.36) GPR6KMT2AKDM4EALDH1A1GAA
SCHEMBL20524576 0.80 GAA (0.39) NNMTPOLBKMT2AROCK2GAA
SCHEMBL20524617 0.73 KMT2A (0.42) GPR6POLBKMT2AKDM4EALDH1A1
SCHEMBL26134016 0.72 KLKB1 (0.36) PARP1
SCHEMBL20524696 0.72 NR4A2 (0.38) GPR6KMT2AALDH1A1GAAMAP3K5
SCHEMBL21724299 0.70 MAP3K5 (0.42) POLBKMT2AKDM4EALDH1A1GAA
SCHEMBL20524627 0.70 POLB (0.41) POLBKMT2AKDM4EALDH1A1HPGD
SCHEMBL24159061 0.70 ROCK2 (0.45) ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110520127-B Piperidinyl-substituted and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6 武田药品工业株式会社 2023-05-16 — — CN disclosed
Send feedback